Helen Gebremicael

Senior Development Associate 1 at Cellerant Therapeutics - San Carlos, California, United States

Helen Gebremicael's Colleagues at Cellerant Therapeutics
Qun Li

Associate Process Development Scientist

Contact Qun Li

Rod Syoc

Sr. Director, Clinical Operations

Contact Rod Syoc

View All Helen Gebremicael's Colleagues
Helen Gebremicael's Contact Details
HQ
Location
San Carlos,California,United States
Company
Cellerant Therapeutics
Helen Gebremicael's Company Details
Cellerant Therapeutics logo, Cellerant Therapeutics contact details

Cellerant Therapeutics

San Carlos, California, United States • 5 Employees
Research

Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. Cellerant's romyelocel-L is a universal cell therapy which does not require HLA matching intended to prevent bacterial and fungal infections during neutropenia. In a randomized, controlled Phase 2 clinical trial in AML patients, romyelocel-L reduced infections and days in hospital. Cellerant is developing two novel antibody drug-conjugate (ADC) products: CLT030 to treat AML by selectively targeting and killing leukemic stem and blast cells, and CSC012-ADC for hematologic malignancies and solid tumor indications.

Details about Cellerant Therapeutics
Frequently Asked Questions about Helen Gebremicael
Helen Gebremicael currently works for Cellerant Therapeutics.
Helen Gebremicael's role at Cellerant Therapeutics is Senior Development Associate 1.
Helen Gebremicael's email address is ***@cellerant.com. To view Helen Gebremicael's full email address, please signup to ConnectPlex.
Helen Gebremicael works in the Research industry.
Helen Gebremicael's colleagues at Cellerant Therapeutics are Qun Li, Rod Syoc, Julie Christensen, Trang Nguyen, Luqman Gbenro, Myralee Martinez and others.
Helen Gebremicael's phone number is
See more information about Helen Gebremicael